SE445174B
(sv)
*
|
1978-03-07 |
1986-06-09 |
Sandoz Ag |
Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
|
SE448386B
(sv)
*
|
1978-10-18 |
1987-02-16 |
Sandoz Ag |
Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
|
EP0034567B1
(fr)
*
|
1980-02-14 |
1984-11-07 |
Sandoz Ag |
Procédé de synthèse totale des cyclosporines ainsi que les nouvelles cyclosporines
|
US4396542A
(en)
*
|
1980-02-14 |
1983-08-02 |
Sandoz Ltd. |
Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
|
US4384996A
(en)
*
|
1981-01-09 |
1983-05-24 |
Sandoz Ltd. |
Novel cyclosporins
|
US5639724A
(en)
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
DE3580717D1
(de)
*
|
1984-08-02 |
1991-01-10 |
Sandoz Ag |
Pharmazeutische anwendung von (nva)2-cyclosporine.
|
GB8422253D0
(en)
*
|
1984-09-04 |
1984-10-10 |
Sandoz Ltd |
Organic compounds
|
EP0198026B1
(fr)
|
1984-10-04 |
1993-08-04 |
Sandoz Ag |
Anticorps monoclonaux contre les cyclosporines
|
US4727035A
(en)
*
|
1984-11-14 |
1988-02-23 |
Mahoney Walter C |
Immunoassay for cyclosporin
|
US4764503A
(en)
*
|
1986-11-19 |
1988-08-16 |
Sandoz Ltd. |
Novel cyclosporins
|
US5427960A
(en)
*
|
1987-03-27 |
1995-06-27 |
Abbott Laboratories |
Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
|
US5239057A
(en)
*
|
1987-03-27 |
1993-08-24 |
Abbott Laboratories |
Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
|
US4798823A
(en)
*
|
1987-06-03 |
1989-01-17 |
Merck & Co., Inc. |
New cyclosporin analogs with modified "C-9 amino acids"
|
DE3851268T2
(de)
*
|
1987-06-19 |
1995-01-26 |
Sandoz Ag |
Zyklische Peptolide.
|
EP0373260B1
(fr)
*
|
1987-06-22 |
1994-03-09 |
Merck & Co. Inc. |
Dérivés de cyclosporine avec un acide aminé modifié en position 8
|
GB8717300D0
(en)
*
|
1987-07-22 |
1987-08-26 |
Nat Res Dev |
Cyclosporins
|
US5227467A
(en)
*
|
1987-08-03 |
1993-07-13 |
Merck & Co., Inc. |
Immunosuppressive fluorinated cyclosporin analogs
|
US4839342A
(en)
*
|
1987-09-03 |
1989-06-13 |
University Of Georgia Research Foundation, Inc. |
Method of increasing tear production by topical administration of cyclosporin
|
EP0391909B1
(fr)
*
|
1987-09-03 |
1994-08-17 |
The University Of Georgia Research Foundation, Inc. |
Composition de cyclosporine oculaire
|
US5236899A
(en)
*
|
1987-11-16 |
1993-08-17 |
Merck & Co., Inc. |
6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
|
US4914188A
(en)
*
|
1987-11-16 |
1990-04-03 |
Merck & Co., Inc. |
Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
|
HU203564B
(en)
*
|
1987-12-21 |
1991-08-28 |
Sandoz Ag |
Process for producing new orthorombos cyclosporin without solvatation
|
HU201567B
(en)
*
|
1988-07-21 |
1990-11-28 |
Gyogyszerkutato Intezet |
Process for production of intravenous medical compositions containing cyclosphorin
|
US5342625A
(en)
*
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
HU201577B
(en)
*
|
1988-12-20 |
1990-11-28 |
Gyogyszerkutato Intezet |
Process for producing cyclosporin antibiotics
|
US7081445B2
(en)
*
|
1989-02-20 |
2006-07-25 |
Novartis Ag |
Cyclosporin galenic forms
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
GB8916901D0
(en)
|
1989-07-24 |
1989-09-06 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
US5122511A
(en)
*
|
1990-02-27 |
1992-06-16 |
Merck & Co., Inc. |
Immunosuppressive cyclosporin analogs with modified amino acids at position-8
|
ATE132504T1
(de)
*
|
1990-08-15 |
1996-01-15 |
Abbott Lab |
Immunotestreagenzien und verfahren zur bestimmung von cyclosporin
|
DE69222150T2
(de)
*
|
1991-01-25 |
1998-01-15 |
Fujisawa Pharmaceutical Co |
Prozess zur produktion von cyclosporin-a und/oder c
|
ES2078374T3
(es)
*
|
1991-04-06 |
1995-12-16 |
Dresden Arzneimittel |
Procedimiento para la produccion por fermentacion y aislamiento de ciclosporina a, y nuevas cepas formadoras de ciclosporina.
|
GB9204466D0
(en)
*
|
1992-03-02 |
1992-04-15 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
EP0725076B1
(fr)
*
|
1995-02-01 |
2001-06-06 |
National Research Development Corporation of India |
Procédé de préparation de la cyclosporine A de l'espèce tolypocladium
|
CN1079837C
(zh)
*
|
1995-02-28 |
2002-02-27 |
国家研究发展公司 |
从分枝层壁菌制备环胞多肽a的方法
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
US5962019A
(en)
*
|
1995-08-25 |
1999-10-05 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
US5834017A
(en)
*
|
1995-08-25 |
1998-11-10 |
Sangstat Medical Corporation |
Oral cyclopsporin formulations
|
US5827822A
(en)
*
|
1996-03-25 |
1998-10-27 |
Sangstat Medical Corporation |
Cyclosporin a formulations as nanoparticles
|
US5747330A
(en)
*
|
1996-06-05 |
1998-05-05 |
Poli Industria Chimica |
Antibiotic producing microbe
|
BR9807528A
(pt)
|
1997-01-30 |
2000-03-14 |
Novartis Ag |
Composições farmacêuticas isentas de óleo contendo ciclosporina a
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
IN188719B
(fr)
*
|
1997-09-08 |
2002-11-02 |
Panacea Biotec Ltd |
|
US20030220234A1
(en)
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
JP4261049B2
(ja)
|
1997-10-08 |
2009-04-30 |
アイソテクニカ インコーポレイテッド |
重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
|
DE69928938T2
(de)
|
1998-07-01 |
2006-08-17 |
Debiopharm S.A. |
Neues cyclosporin mit verbesserter wirkung
|
EP2116228A1
(fr)
*
|
2001-10-19 |
2009-11-11 |
Isotechnika Inc. |
Nouveaux préconcentrés de microémulsion analogue de cyclosporine
|
PL210795B1
(pl)
|
2001-10-19 |
2012-03-30 |
Isotechnika Inc |
Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
|
US20060014677A1
(en)
*
|
2004-07-19 |
2006-01-19 |
Isotechnika International Inc. |
Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
|
US7511013B2
(en)
|
2004-09-29 |
2009-03-31 |
Amr Technology, Inc. |
Cyclosporin analogues and their pharmaceutical uses
|
EP1809656A4
(fr)
|
2004-09-29 |
2009-03-25 |
Amr Technology Inc |
Analogues d'alcyne de cyclosporine et utilisations pharmaceutiques de ceux-ci
|
US7361636B2
(en)
|
2004-10-06 |
2008-04-22 |
Amr Technology, Inc. |
Cyclosporin alkynes and their utility as pharmaceutical agents
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US7696166B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
WO2008036244A1
(fr)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Utilisation de cyclosporine a pour sensibiliser des cellules cancéreuses résistantes à des ligands de récepteur de mort
|
TW200932240A
(en)
|
2007-10-25 |
2009-08-01 |
Astellas Pharma Inc |
Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
|
CN102365094A
(zh)
*
|
2009-01-30 |
2012-02-29 |
英安塔制药有限公司 |
用于预防或者治疗肝炎感染的环孢菌素类似物
|
US8481483B2
(en)
*
|
2009-02-19 |
2013-07-09 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
US8349312B2
(en)
*
|
2009-07-09 |
2013-01-08 |
Enanta Pharmaceuticals, Inc. |
Proline substituted cyclosporin analogues
|
US8367053B2
(en)
*
|
2009-07-09 |
2013-02-05 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
US8685917B2
(en)
*
|
2009-07-09 |
2014-04-01 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
US8623814B2
(en)
*
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
DK2651965T3
(en)
|
2010-12-15 |
2019-02-18 |
Contravir Pharmaceuticals Inc |
CYCLOSPORIN ANALOGUAL MODULES MODIFIED BY AMINO ACID 1 AND 3
|
WO2012125569A2
(fr)
|
2011-03-11 |
2012-09-20 |
Beth Israel Deaconess Medical Center, Inc. |
Anticorps anti-cd40 et leurs utilisations
|
WO2012145427A1
(fr)
|
2011-04-18 |
2012-10-26 |
The Trustees Of Columbia University In The City Of New York |
Méthodes de traitement du cancer à l'aide de cyclosporine et de dérivés de cyclosporine
|
US8906853B2
(en)
|
2012-11-28 |
2014-12-09 |
Enanta Pharmaceuticals, Inc. |
[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
|
RU2016110247A
(ru)
|
2013-08-26 |
2017-10-02 |
Энанта Фармасьютикалс, Инк. |
Аналоги циклоспорина для предупреждения или лечения гепатита с
|
US9669095B2
(en)
|
2014-11-03 |
2017-06-06 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues for preventing or treating hepatitis C infection
|
CN116063481A
(zh)
|
2015-09-04 |
2023-05-05 |
普里玛托普医疗股份有限公司 |
人源化抗-cd40抗体及其用途
|